BeiGene Ltd. ADR | Key People and Executives
John V. Oyler
Chairman & Chief Executive Officer
Yong Zheng Chen
Independent Director
Thomas R. Malley
Independent Director
Qingqing Yi
Independent Director
Ronny Krishana
Independent Director
Donald W. Glazer
Independent Director
Michael J. Goller
Independent Director
John V. Oyler
Chairman & Chief Executive Officer
Maggie Liu
Head-Operations
Howard Liang
Chief Financial & Strategy Officer
Jane E Huang
Chief Medical Officer-Hematology
Amy C. Peterson
Chief Medical Officer-Immuno-Oncology
Wendy Yan
Senior VP & Head-Global Regulatory Affairs
Alice Kang
Head-Clinical Development
Guillaume Vignon
Senior Vice President-Business Development
Ross D. Pettit
Senior VP-Global Development Operations
Xin Bian
Co-Chief Commercial Officer & Head-Marketing
Yi Fei Zhu
Co-Chief Commercial Officer, Head-Sales & Market
Liza Heapes
Media Contact
Lucy Li
Investor Relations Contact
Scott A. Samuels
Senior Vice President & General Counsel
Yong Zheng Chen
Independent Director
Thomas R. Malley
Independent Director
Qing Qing Yi
Independent Director
Ronny Krishana
Independent Director
Donald W. Glazer
Independent Director
Michael J. Goller
Independent Director
| Address |
Zhongguancun Life Science Park
Beijing Beijing 102206
China
|
|
Employees
|
- |
| Website |
http://www.beigene.com |
| Updated |
07/08/2019 |
| BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. |
